An observational study in Scoliosis, sponsored by Istituto Ortopedico Rizzoli. Completed at 1 site in Italy. Open to participants aged 5 Years to 20 Years. Per ClinicalTrials.gov, last updated 2023-09-26.
Sponsored by Istituto Ortopedico Rizzoli · Observational
The aim of the study is to evaluate the diagnostic accuracy of low-dose dual energy CT in the pre-surgical planning of patients with progression of scoliosis
CT imaging is the gold standard for assessing bone dysmorphism and vertebral morphometry during the pre-surgical planning of vertebral arthrodesis. It is necessary in the definition of the fixation points to avoid malposition of transpedicular screws and potential visceral, vascular or neurological damage.
It is known that multislice CT involves an increased radiation exposure for patients, while dual-energy CT uses a low-dose acquisition protocol and VEO reconstruction software.
The aim of the study is to evaluate the diagnostic accuracy of low-dose dual energy CT in the pre-surgical planning of patients with progression of scoliosis who are candidated for vertebral arthrodesis.
660 studies on the registry are indexed under Scoliosis; 186 are open to participants now.
This study's enrollment of 64 is below the median of 84 across 256 observational studies indexed under Scoliosis.
Browse Scoliosis studies →Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with progression of scoliosis selected at the Rizzoli Orthopaedic Institute
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Low-dose dual-energy CT imaging
Diagnostic accuracy
To evaluate the percentage of malpositioning of transpedicular screw. A percentage of malpositioning lower than 10% will be considered as acceptable.
Time frame: Week 1 (post-surgery)
Radiation exposure
Collection of dosimetric data
Time frame: Baseline (pre-surgery) and week 1 (post-surgery)
Ran from Jan 2018 to primary completion in Dec 2019, 23 months.
Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's 23 months is below that.
Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.